TickerFactsScreenerDevelopers

IGC Pharma, Inc. (IGC) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2011: $3.91M2012: $4.82M2013: $6.50M2014: $1.89M2015: $7.10M2016: $5.52M2017: $362.1K2018: $2.11M2019: $4.98M2020: $3.96M2021: $785.0K2022: $203.0K2023: $469.0K2024: $612.0K2025: $652.0K$652.0K
2011Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$652.0K+6.5%
2024$612.0K+30.5%
2023$469.0K+131.0%
2022$203.0K-74.1%
2021$785.0K-80.2%
2020$3.96M-20.6%
2019$4.98M+136.1%
2018$2.11M+482.9%
2017$362.1K-93.4%
2016$5.52M-22.2%
2015$7.10M+275.4%
2014$1.89M-70.9%
2013$6.50M+34.8%
2012$4.82M+23.1%
2011$3.91M—